Avital Zeldin
Papers
1
Total Citations
1
H-Index
1
About
Dr. Avital Zeldin is a urologic surgeon and researcher whose work focuses on advancing minimally invasive treatments for benign prostatic hyperplasia (BPH) and managing their associated complications. Her major contributions include the first detailed case report of severe hemorrhage following robotic-assisted Aquablation, a novel water-jet ablation technique for BPH. In this landmark 2025 publication, Dr. Zeldin documented an 84-year-old patient who developed life-threatening hematuria and hemodynamic instability post-procedure, providing critical insights into the failure of conventional hemostatic measures and the need for aggressive intervention. This work, which has already garnered citations, establishes her as a key voice in procedural safety and complication management. Dr. Zeldin’s research bridges the gap between innovative surgical technologies and real-world patient outcomes, offering practical guidance for urologists adopting Aquablation. Her findings underscore the importance of preparedness for rare but severe adverse events, directly impacting clinical protocols and patient counseling. With a growing citation footprint, Dr. Zeldin is poised to shape the future of BPH treatment through her commitment to evidence-based refinement of cutting-edge urologic techniques.
Research Focus
Key Achievements
Top Papers
- 1Severe hemorrhage post robotic-assisted Aquablation: A case report1 citations · 2025